COMPLEMENT ACTIVATION BY ANTIBODY N-GLYCANS
COMPLEMENT ACTIVATION BY ANTIBODY N-GLYCANS
批准号:
6373664
负责人:
FRANK J WAXMAN
金额:
$23.75万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-07-01 至 2004-06-30
中文摘要
描述(改编自《调查者摘要》):N-葡聚糖
免疫球蛋白(Ig)可以在以下方面发挥深远的作用
它们的生物学功能。这项研究是由自相矛盾的
观察到同型相合的单抗在它们的
激活经典补体途径的能力。一对IgG2a抗体
具有相似的单糖组成,但与凝集素的结合不同。
当抗体变性时,这些特性就消失了,这表明
原生抗体之间的差异反映了N-糖链的取向,而不是
多聚糖本身的凝集素结合能力。使用以下工具进行实验
支持糖基转移酶和糖苷酶探测N-糖链的可及性
这个假说。糖基转移酶的相对易感性和
糖苷酶和对凝集素的可及性与这种能力呈负相关
与补体的初始反应成分C1q结合的两个抗体中的一个
系统的经典路径。抗体的脱糖基化程度越高
可获得的多糖增强了其激活补体的能力,这表明
更易接近的多糖可能会抑制C1q结合。相比之下,删除
另一种单抗多糖降低了其补体激活潜力。有几个
这两个抗体的可变区有许多序列差异,但
编码它们的重链恒定区的序列是相同的,这表明
该可变结构域序列会影响恒定序列中的多糖取向
区域。一对具有相似特征的同型匹配的人类抗体具有
也被确认了。这项提议试图定义免疫球蛋白的影响
利用重组和重组技术研究N-糖链的可变区
然后突变了人和鼠的抗体。多聚糖的详细结构分析
还将执行与功能相关的结构。其他内容
实验将确定使用同种类型匹配对的观测结果
以单抗作为初始模型系统代表了更一般的生物学
现象并确定多糖调节的补体激活是否会影响
免疫球蛋白的其他生物学特性,如清除来自
肾小球内的循环和沉积。初步观察结果和
提出的研究代表了我们对
ABS激活补体系统,将提供有价值的见解
自身免疫和其他炎症性疾病的发病机制以及
重组治疗性抗体的合理设计。
英文摘要
DESCRIPTION (Adapted from Investigator's Abstract): N-glycans on
immunoglobulins (Igs) can play a profound and hitherto unappreciated role in
their biological function. This study was prompted by the paradoxical
observation that isotype-matched monoclonal antibodies (Abs) differed in their
capacities to activate the classical complement pathway. A pair of IgG2a Abs
had similar monosaccharide composition yet differed in binding to lectins.
These properties were lost when the Abs were denatured, suggesting that
differences between the native Abs reflected N-glycan orientation rather than
the lectin binding capacity of the glycans themselves. Experiments using
glycosyltransferases and glycosidases to probe N-glycan accessibility supported
this hypothesis. The relative susceptibility to glycosyltransferases and
glycosidases and accessibility to lectins was inversely related to the ability
of the two Abs to bind C1q, the initial reactive component of the complement
system's classical pathway. Deglycosylation of the Ab bearing the more
accessible glycan enhanced its capacity to activate complement, suggesting that
the more accessible glycan might inhibit C1q binding. In contrast, removal of
the other Abs glycan reduced its complement activation potential. There were
many sequence differences in the variable domains of the two Abs but the
sequence encoding their heavy chain constant regions was identical, suggesting
that variable domain sequence affects glycan orientation in the constant
region. An isotype-matched pair of human Abs with similar characteristics has
also been identified. This proposal seeks to define the influence of Ig
variable (V) domains on the orientation of the N-glycan using recombinant and
then mutated human and mouse Abs. A detailed structural analysis of glycan
structure in relation to function will also be performed. Additional
experiments will determine if the observations using the isotype-matched pairs
of Abs as an initial model system represent a more general biological
phenomenon and determine if glycan-modulated complement activation affects
other biological properties of Igs such as clearance of immune complexes from
the circulation and deposition in glomeruli. The preliminary observations and
proposed studies represent a fundamental paradigm shift in our understanding of
Abs activate the complement system and will provide valuable insights into the
pathogenesis of autoimmune and other inflammatory diseases as well as in the
rational design of recombinant therapeutic Abs.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Glomerular deposition of immune complexes made with IgG2a monoclonal antibodies.
用 IgG2a 单克隆抗体制成的免疫复合物沉积在肾小球。
DOI:
10.4049/jimmunol.164.2.1071
发表时间:
2000
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[Gonzalez,ML, Waxman,FJ]
通讯作者:
Waxman,FJ
UNDERGRADUATE ACITIVITIES AND OUTREACH
-
批准号:7960021
-
项目类别:
-
资助金额:$32.65万
-
财政年份:2009
-
负责人:FRANK J WAXMAN
-
依托单位:
ADMINISTRATIVE CORE
-
批准号:7960014
-
项目类别:
-
资助金额:$77.64万
-
财政年份:2009
-
负责人:FRANK J WAXMAN
-
依托单位:
ADMINISTRATIVE CORE
-
批准号:7725092
-
项目类别:
-
资助金额:$70.45万
-
财政年份:2008
-
负责人:FRANK J WAXMAN
-
依托单位:
UNDERGRADUATE ACITIVITIES AND OUTREACH
-
批准号:7725099
-
项目类别:
-
资助金额:$29.63万
-
财政年份:2008
-
负责人:FRANK J WAXMAN
-
依托单位:
UNDERGRADUATE ACITIVITIES AND OUTREACH
-
批准号:7610279
-
项目类别:
-
资助金额:$22.1万
-
财政年份:2007
-
负责人:FRANK J WAXMAN
-
依托单位:
ADMINISTRATIVE CORE
-
批准号:7610272
-
项目类别:
-
资助金额:$61.25万
-
财政年份:2007
-
负责人:FRANK J WAXMAN
-
依托单位:
ADMINISTRATIVE CORE
-
批准号:7381656
-
项目类别:
-
资助金额:$57.3万
-
财政年份:2006
-
负责人:FRANK J WAXMAN
-
依托单位:
UNDERGRADUATE ACITIVITIES AND OUTREACH
-
批准号:7381663
-
项目类别:
-
资助金额:$25.96万
-
财政年份:2006
-
负责人:FRANK J WAXMAN
-
依托单位:
UNDERGRADUATE ACITIVITIES AND OUTREACH
-
批准号:7170901
-
项目类别:
-
资助金额:$27.28万
-
财政年份:2005
-
负责人:FRANK J WAXMAN
-
依托单位:
ADMINISTRATIVE CORE
-
批准号:7170894
-
项目类别:
-
资助金额:$56.4万
-
财政年份:2005
-
负责人:FRANK J WAXMAN
-
依托单位:
OK BRIN: ADMINISTRATIVE CORE
-
批准号:6973111
-
项目类别:
-
资助金额:$116.76万
-
财政年份:2004
-
负责人:FRANK J WAXMAN
-
依托单位:
Oklahoma IDeA Network of Biomedical Research Excellence
-
批准号:7099574
-
项目类别:
-
资助金额:$348.09万
-
财政年份:2001
-
负责人:FRANK J WAXMAN
-
依托单位:
Oklahoma IDeA Network of Biomedical Research Excellence
-
批准号:6813348
-
项目类别:
-
资助金额:$363.73万
-
财政年份:2001
-
负责人:FRANK J WAXMAN
-
依托单位:
Oklahoma IDeA Network of Biomedical Research Excellence
-
批准号:6914365
-
项目类别:
-
资助金额:$352.47万
-
财政年份:2001
-
负责人:FRANK J WAXMAN
-
依托单位:
Oklahoma IDeA Network of Biomedical Research Excellence
-
批准号:7221994
-
项目类别:
-
资助金额:$342.38万
-
财政年份:2001
-
负责人:FRANK J WAXMAN
-
依托单位:
Oklahoma Biomedical Research Infrastructure Network
-
批准号:6530161
-
项目类别:
-
资助金额:$200.0万
-
财政年份:2001
-
负责人:FRANK J WAXMAN
-
依托单位:
Oklahoma Biomedical Research Infrastructure Network
-
批准号:6413279
-
项目类别:
-
资助金额:$199.85万
-
财政年份:2001
-
负责人:FRANK J WAXMAN
-
依托单位:
Oklahoma IDeA Network of Biomedical Research Excellence
-
批准号:7414544
-
项目类别:
-
资助金额:$335.53万
-
财政年份:2001
-
负责人:FRANK J WAXMAN
-
依托单位:
Oklahoma Biomedical Research Infrastructure Network
-
批准号:6652598
-
项目类别:
-
资助金额:$241.86万
-
财政年份:2001
-
负责人:FRANK J WAXMAN
-
依托单位:
COMPLEMENT ACTIVATION BY ANTIBODY N-GLYCANS
-
批准号:6170485
-
项目类别:
-
资助金额:$23.46万
-
财政年份:1999
-
负责人:FRANK J WAXMAN
-
依托单位:
海外基金